5I3D image
Deposition Date 2016-02-10
Release Date 2017-02-01
Last Version Date 2024-01-10
Entry Detail
PDB ID:
5I3D
Keywords:
Title:
Sulfolobus solfataricus beta-glycosidase - E387Y mutant
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.16 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Beta-galactosidase
Gene (Uniprot):lacS
Mutations:E387Y
Chain IDs:A, B, C, D
Chain Length:489
Number of Molecules:4
Biological Source:Sulfolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2)
Primary Citation
A front-face 'SNi synthase' engineered from a retaining 'double-SN2' hydrolase.
Nat. Chem. Biol. 13 874 881 (2017)
PMID: 28604696 DOI: 10.1038/nchembio.2394

Abstact

SNi-like mechanisms, which involve front-face leaving group departure and nucleophile approach, have been observed experimentally and computationally in chemical and enzymatic substitution at α-glycosyl electrophiles. Since SNi-like, SN1 and SN2 substitution pathways can be energetically comparable, engineered switching could be feasible. Here, engineering of Sulfolobus solfataricus β-glycosidase, which originally catalyzed double SN2 substitution, changed its mode to SNi-like. Destruction of the first SN2 nucleophile through E387Y mutation created a β-stereoselective catalyst for glycoside synthesis from activated substrates, despite lacking a nucleophile. The pH profile, kinetic and mutational analyses, mechanism-based inactivators, X-ray structure and subsequent metadynamics simulations together suggest recruitment of substrates by π-sugar interaction and reveal a quantum mechanics-molecular mechanics (QM/MM) free-energy landscape for the substitution reaction that is similar to those of natural, SNi-like glycosyltransferases. This observation of a front-face mechanism in a β-glycosyltransfer enzyme highlights that SNi-like pathways may be engineered in catalysts with suitable environments and suggests that 'β-SNi' mechanisms may be feasible for natural glycosyltransfer enzymes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures